From: A forced titration study of the antioxidant and immunomodulatory effects of Ambrotose AO supplement
Secondary Outcome Measure | Effect | Â | Mean | SE | Pairwise | p value |
---|---|---|---|---|---|---|
Mature B Cell Number | Smoker | No | 0.25 | 0.03 | Â | 0.028 |
 |  | Yes | 0.35 | 0.04 |  |  |
Natural Killer Cell Number | Smoker | No | 0.20 | 0.02 | Â | 0.003 |
 |  | Yes | 0.27 | 0.02 |  |  |
Phagocytosis of Granulocytes | Dose | Baseline | 45.01 | 1.43 | base vs 8 | 0.002 |
 |  | 1 | 43.70 | 2.17 | 1 vs 8 | 0.038 |
 |  | 2 | 50.68 | 2.89 | 2 vs 4 | 0.010 |
 |  | 4 | 42.81 | 1.65 | 4 vs 8 | 0.000 |
 |  | 8 | 50.49 | 1.58 |  |  |
 | Gender | Male | 43.70 | 2.18 |  | 0.038 |
 |  | Female | 49.37 | 1.73 |  |  |
Phagocytosis of Granulocytes | Dose | Baseline | 45.01 | 1.44 | base vs 8 | 0.001 |
   (4 capsule dose excluded) |  | 1 | 43.96 | 2.19 | 1 vs 8 | 0.026 |
 |  | 2 | 50.36 | 2.92 |  |  |
 |  | 8 | 50.47 | 1.54 |  |  |
 | Gender | Male | 44.64 | 2.23 |  | 0.035 |
 |  | Female | 50.27 | 1.78 |  |  |
Phagocytosis of Monocytes | Dose | Baseline | 34.37 | 0.89 | 2 vs 4 | 0.003 |
 |  | 1 | 33.24 | 1.38 |  |  |
 |  | 2 | 35.76 | 1.83 |  |  |
 |  | 4 | 32.01 | 1.27 |  |  |
 |  | 8 | 32.70 | 1.41 |  |  |
 | Gender | Male | 31.43 | 1.29 |  | 0.007 |
 |  | Female | 35.80 | 1.02 |  |  |
Phagocytosis of Monocytes | Gender | Male | 32.03 | 1.39 | Â | 0.022 |
   (4 capsule dose excluded) |  | Female | 35.93 | 1.09 |  |  |
Natural Killer Cell Cytotoxicity | Gender | Male | 19.41 | 1.70 | Â | 0.04 |
 |  | Female | 14.77 | 1.28 |  |  |
Cox 2. | Dose | Baseline | 80.42 | 1.06 | base vs 1 | 0.047 |
 |  | 1 | 83.77 | 0.79 |  |  |
 |  | 2 | 81.99 | 0.73 |  |  |
 |  | 4 | 81.69 | 1.07 |  |  |
 |  | 8 | 81.80 | 1.26 |  |  |